Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Nothofagin

Nothofagin
Nothofagin has antioxidant, and antithrombotic activities, it possesses anti-inflammatory activity by inhibiting hyperpermeability, expression of CAMs, and adhesion and migration of leukocytes, thereby endorsing its usefulness as a therapy for vascular inflammatory diseases.
Catalog No. TN1996Cas No. 11023-94-2
Select Batch
Purity:99.21%
Contact us for more batch information
Resource Download

Nothofagin

Catalog No. TN1996Cas No. 11023-94-2
Nothofagin has antioxidant, and antithrombotic activities, it possesses anti-inflammatory activity by inhibiting hyperpermeability, expression of CAMs, and adhesion and migration of leukocytes, thereby endorsing its usefulness as a therapy for vascular inflammatory diseases.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
1 mg$489In Stock
5 mg$1,090In Stock
10 mg$1,480In Stock
25 mg$2,230In Stock
50 mg$2,930In Stock
100 mg$3,970In Stock
1 mL x 10 mM (in DMSO)$1,230In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Nothofagin"

Product Introduction

Bioactivity
Description
Nothofagin has antioxidant, and antithrombotic activities, it possesses anti-inflammatory activity by inhibiting hyperpermeability, expression of CAMs, and adhesion and migration of leukocytes, thereby endorsing its usefulness as a therapy for vascular inflammatory diseases.
In vitro
Pre-treatment of DNPHSA-stimulated RBL-2H3 with 10 μM Nothofagin markedly suppresses the phosphorylation of Lyn, Syk, and Akt. Nothofagin pre-treatment (0.1, 1, 10 μM) decreases the level of histamine release in RBL-2H3 and RPMCs cells. Furthermore, Nothofagin suppresses IgE-mediated mast cell degranulation both in vitro and in vivo [1].
In vivo
Oral administration of matrine at 1 mg/kg per day for 7 consecutive days significantly increases the urinary volume of both normotensive (NTR) and spontaneously hypertensive rats (SHR) [2].
Chemical Properties
Molecular Weight436.41
FormulaC21H24O10
Cas No.11023-94-2
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 25 mg/mL (57.29 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2914 mL11.4571 mL22.9142 mL114.5712 mL
5 mM0.4583 mL2.2914 mL4.5828 mL22.9142 mL
10 mM0.2291 mL1.1457 mL2.2914 mL11.4571 mL
20 mM0.1146 mL0.5729 mL1.1457 mL5.7286 mL
50 mM0.0458 mL0.2291 mL0.4583 mL2.2914 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Nothofagin | purchase Nothofagin | Nothofagin cost | order Nothofagin | Nothofagin chemical structure | Nothofagin in vivo | Nothofagin in vitro | Nothofagin formula | Nothofagin molecular weight